Loading patent…
AssigneeChengdu Easton Biopharmaceuticals Co., Ltd.
InventorsYing Wang, Long Huang, Yongzhe Xiang, Guodong Cen, Jianguo Li, Jianjing Jia, Qiangqiang Liu, Yang Liu, Haitao Yang, Qing Dong
Estimating the term…
Provided a complex of formula is [3-((1S, 3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate-(S)-3′-methyl-2′-(pentanoyl {2″-(tetrazol-5-ylate) biphenyl-4′-ylmethyl}amino) butyrate]6.XCa2+.YNa+.ZH2O, wherein X=1-3, Y=12-16, Z=9-18, and 2X+Y=18, and represented by formula (I). Also disclosed are the method of preparing the complex and the method of treating chronic heart disease using a medicament comprising the complex.
A complex of sodium calcium [3-((1S, 3R)-1-biphenyl-4-ylmethyl-3-ethoxy carbonyl-1-butylcarbamoyl)propionate-(S)-3′-methyl-2′-(pentanoyl {2″-(tetrazol-5-ylate)biphenyl4′-ylmethyl}amino)butyrate].
Dependencies are inferred from the claim text.